BlackRock Institutional Trust’s Genesis Healthcare, Inc. GEN Stock Holding History

BlackRock Institutional Trust’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.64M	Sell	856,025 -4,555	-0.5%	-$15K	﹤0.01%	2838
2016 Q3	$2.3M	Buy	860,580 +6,145	+0.7%	+$14.1K	﹤0.01%	2998
2016 Q2	$1.51M	Sell	854,435 -5,650	-0.7%	-$11.5K	﹤0.01%	3153
2016 Q1	$2M	Sell	860,085 -7,325	-0.8%	-$16.6K	﹤0.01%	3045
2015 Q4	$3.01M	Buy	867,410 +19,821	+2%	+$94.9K	﹤0.01%	2942
2015 Q3	$5.2M	Sell	847,589 -21,368	-2%	-$145K	﹤0.01%	2699
2015 Q2	$5.74M	Buy	868,957 +73,840	+9%	+$498K	﹤0.01%	2712
2015 Q1	$5.66M	Buy	+795,117	New	+$6M	﹤0.01%	2712

Other funds holding GEN

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's GEN Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Genesis Healthcare, Inc. (GEN) stake by 0.53% in Q4 2016, selling an estimated $15K and leaving 856,025 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

BlackRock Institutional Trust first reported a position in GEN in Q1 2015 and has held it in 8 quarters since. The position peaked at $5.74M in Q2 2015. 77 funds tracked by Wall St. Rank hold GEN as of Q4 2016.

BlackRock Institutional Trust held 856,025 shares of Genesis Healthcare, Inc. worth $3.64M as of Q4 2016.
BlackRock Institutional Trust sold 4,555 Genesis Healthcare, Inc. shares in Q4 2016, an estimated $15K.
Genesis Healthcare, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2838 holding.
BlackRock Institutional Trust first reported a position in Genesis Healthcare, Inc. in Q1 2015 and has held it in 8 quarters since.
BlackRock Institutional Trust's Genesis Healthcare, Inc. position peaked at $5.74M in Q2 2015.
77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.